2 research outputs found

    Contemporary Consortium of Periodontal Diseases and Atherosclerotic Cardiovascular Diseases- A Narrative Review

    Get PDF
    Periodontal medicine unravels the relationship between periodontal health and disease with systemic health and disease. Periodontal disease serves as a niche for abundant quantity of microorganisms and their byproducts that disseminate into the blood stream. This systemic spread of endotoxins is directly related to the amount of periodontal destruction occurring at any given point of time and is responsible for bridging the link between inflammatory periodontal disease and various other systemic diseases. It is a well-known fact that periodontal diseases have been linked to various systemic diseases including osteoporosis, kidney diseases, adverse pregnancy outcomes, diabetes and even atherosclerotic cardiovascular diseases. Both periodontal diseases and atherosclerotic cardiovascular diseases share the same risk factors. Although both the diseases are multifactorial, the complex pathogenic mechanism orchestrating periodontal and atherosclerotic cardiovascular diseases share a considerate portion of the proinflammatory trait and several biochemical mediators play a role in the pathogenesis and inflammatory response in periodontitis caused by bacterial infections, linking chronic periodontitis to atherosclerotic cardiovascular disease. This review focuses on enlightening the plausible mechanisms that link periodontal and cardiovascular diseases and highlights the various other aspects of periodontal medicine that establishes a two-way relationship between periodontal diseases and atherosclerotic cardiovascular diseases. Understanding the nature of this association would ultimately aid clinicians to carefully plan treatment for patients and emphasise the importance of maintaining optimal oral hygiene in atherosclerotic patients in a more comprehensive and acceptable manner

    Effect of Low-level Laser Therapy and Platelet-rich Fibrin on the Treatment of Intra-bony Defects

    Get PDF
    Introduction: Attempts to regenerate the periodontal osseous defect, which is lost as a result of periodontal disease, require the tapping of the innate healing potential of periodontium through appropriately designed therapeutic strategies. A multitude of grafted and non-grafted approaches have been used in the management of Intra-bony defects. However, they do not provide predictable periodontal regeneration. The aim of this study was to evaluate the combined effect of low-level laser therapy (LLLT) and platelet-rich fibrin (PRF), in site modulated intra-bony defects (decortication), which were accessed using a simplified papilla preservation flap (SPPF), on the clinical and radiographic outcomes of periodontal disease.Methods: A total of 30 patients with intra-bony defects were recruited for the study and randomly distributed in two groups (n=15). Test group sites were accessed with SPPF and the defects received intra-marrow Penetration (IMP) following debridement and were irradiated with a low-level laser followed by PRF grafting and suturing done. The control group defects were accessed with SPPF and grafted with PRF before being secured by sutures. The plaque and bleeding score, PPD, CAL, and the position of the gingival margin with radiographic defect depth were recorded and analyzed at baseline and six months post-intervention using the student’s t-test and Wilcoxon signed-rank test.Results: The test group showed a clinically relevant increase in mean PPD reduction, CAL gain, and radiographic bone fill (3.6 ± 1.35 mm, 3.26 ± 1.16 mm, and 2.44 ± 1.24 mm) compared to the control group (2.93 ±1.1 mm, 2.267 ± 1.33 mm and 1.26 ± 0.99 mm) six months post-intervention. However, intergroup comparison between the test and control groups did not show any statistically significant difference.Conclusion: These results highlight that test protocol had greater amelioration of the effects of periodontal disease and all the investigated clinical and radiographic parameters showed considerable improvement from baseline to 6 months within the test and control group, but intergroup comparison between the test and control groups did not show any statistically significant difference, indicating statistical equivalence between the test and control protocol
    corecore